Regulatory

Regulatory  ·  Weekly Digest - 04 July to 10 July
Hengrui ADC innovative drug Ruikang Trastuzumab new indication marketing application accepted and included in priority review

Weekly Digest – July 2026 Weekly Digest – July 2026 8 July 2026: Hengrui ADC innovative drug Ruikang Trastuzumab new indication marketing application accepted and included in priority review Hengrui Pharma’s HER2-targeted antibody-drug conjugate Trastuzumab rezetecan has had its new […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 21 to 27 June 2025
Dong-A ST files IND for Phase 1 clinical trial of ADC candidate for cancer

Weekly Digest – June 2025 Weekly Digest – June 2025 24 June 2025: Dong-A ST files IND for Phase 1 clinical trial of ADC candidate for cancer Dong-A ST’s ADC subsidiary, Aptis, has submitted an IND application in South Korea […]

by Sandhya Ramalingam

Continue Reading